Dr. Charles Benjamin Bird, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 54 Leisure Ln, Siletz, OR 97380 Phone: 541-444-7585 Fax: 541-444-1121 |
News Archive
In a new paper published by Nature Communications, The Lundquist Institute (TLI) Investigator Wei Yan, MD, PhD, and his research colleagues spell out an innovative strategy that has led to the discovery of a natural compound as a safe, effective and reversible male contraceptive agent in pre-clinical animal models
Bruise detection and diagnosis is currently conducted by sight, under regular light, and bruises are often difficult to see on victims of violence depending on their skin color and the age of their injury.
Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.
BMG LABTECH's visual appearance is heading into a new direction. The microplate reader company launched a new corporate colour identity that will be rolled out across all products as well as external and internal communication channels in the coming weeks.
› Verified 4 days ago